Keyphrases
Phospholamban
100%
Cardiomyopathy
100%
Early Manifestation
100%
Protein Aggregation
100%
Disease Onset
18%
Inflammation
9%
Cardiac Function
9%
Mass Spectrometry
9%
Mouse Model
9%
Pathophysiology
9%
Heart Failure
9%
Proteomics
9%
Differential Regulation
9%
Contractility
9%
Clinically Significant
9%
Ischemic Heart Disease
9%
Transcriptomics
9%
Expression Level
9%
Myocardial Infarction
9%
Altered Proteins
9%
Cardiac Tissue
9%
Myocardial Fibrosis
9%
Echocardiography
9%
Initial Manifestation
9%
Aggregate Formation
9%
RNA Sequencing (RNA-seq)
9%
Functional Deficits
9%
Myocardial Ischemia-reperfusion
9%
Tissue Analysis
9%
Targets for Therapy
9%
Ventricular Dilatation
9%
Pathogenic Variants
9%
Proteostasis
9%
Protein Homeostasis
9%
Metabolic Dysfunction
9%
Global Longitudinal Strain
9%
Biochemistry, Genetics and Molecular Biology
Protein Aggregation
100%
Phospholamban
100%
Mouse
36%
Protein Homeostasis
18%
Electrocardiogram
18%
Mouse Model
9%
Proteomics
9%
Heart Function
9%
RNA Sequence
9%
Transcriptomics
9%
Muscle Contractility
9%
Reperfusion
9%
Mass Spectrometry
9%
Electric Potential
9%
Dilatation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiomyopathy
100%
Phospholamban
100%
Mouse
36%
Disease
27%
Pathophysiology
9%
Heart Failure
9%
Heart Infarction
9%
Ischemic Heart Disease
9%
Heart Muscle Ischemia
9%
Inflammation
9%
Mouse Model
9%
Heart Muscle Fibrosis
9%
RNA-Sequencing
9%